BURKHARD BLANK
CIK 1073409 · EVP Chief Medical Officer · last filed 2025-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.69M
Companies
3
Total Filings
25
Lifetime Open-Market Net
-$1.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNKD | EVP Chief Medical Officer | 460,791 | $3.66 | $1.69M | $0 | 7 | 2025-07-17 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | CMO and Head of R&D | 18,527 | $0.66 | $12.2K | -$1.33M | 14 | 2021-03-05 |
| Altus Pharmaceuticals Inc. (ALTU) Delisted | EVP & Chief Medical Officer | — | $10.12 | — | $0 | 4 | 2008-05-27 |
Recent Filings · Page 2 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-12 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +9,045 | $0 | EDGAR |
| 2018-12-27 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +2,100 | $0 | EDGAR |
| 2018-09-12 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +2,100 | $0 | EDGAR |
| 2018-08-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Mixed | — | -$51.2K | EDGAR |
| 2018-07-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −5,000 | -$148.1K | EDGAR |
| 2018-05-22 | Acorda Therapeutics, Inc. (ACOR) Delisted | Mixed | — | -$179.1K | EDGAR |
| 2017-12-05 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −11,050 | -$226.9K | EDGAR |
| 2017-05-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +4,200 | $0 | EDGAR |
| 2016-12-05 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −10,000 | -$207.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.